If you have owned this company for 24 years - NO MATTER
If you have owned this company for 24 years - NO MATTER WHAT ANYONE ELSE SAYS - you are entitled to say what ever the f you want.... plain and simple....
There is not one soul on this board who should be arguing or giving crap to anyone who has been here for that long... I myself have been here since 2000 - 01? I ignore the "I am smarter than you" crap some newer investors spout... Fact is I see it as I was smarter BEFORE you...
I cannot tell you how much I have lost on this company. but I am looking forward to gaining it all back someday....
Now STFU - Stop your wishy washy complaining and get back on this side of the fence.... The grass is not always greener on the basher side, and quite frankly - you were not that good at it.
And thank you for posting pics again... I was worried about you for a moment
yeah - I need coffee....
Baltia Air Lines Inc (BLTA) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Global Stage for Pet Nutrition Science The folks over at the Purina Institute are back in the spotlight as they gear up to throw their weight behind the 51st World Small Animal Veterinary Association (WSAVA) Congress in Warsaw, Poland. Set for October 13-15, 2026, this isn’t just another event—they're bringing some serious clout with their 'Food for Thought'...
Continue Reading
Visionary Steps Toward a Brighter Future No two words could describe the task that Cure Blindness Project is tackling this year: vision and action. Marking World Sight Day on October 8, they plan to usher in 770,000 eye screenings across Asia, Africa, and the Caribbean. These initiatives aren't just numbers—they're a colossal step toward lifting the veil of avoidable...
Continue Reading
Has anyone else noticed just how fast the world spins when it comes to consumer trends these days? Bob Evans is hopping right on the protein bandwagon with its latest launch, a microwave-ready Protein Macaroni & Cheese that packs 18 grams of protein per serving. You gotta hand it to them for seizing opportunity when they see it. This one's not just about tossing a new...
Continue Reading
Truss Financial Group's Bold Move Against Closing Delays In real estate, time is money. Even the most casual market observer could tell you delays can slice through a deal like a hot knife through butter. That's the headache home equity borrowers face, blindsided by closing delays that sneak up on them without warning. An Industry Bottleneck Finally Addressed Enter Truss...
Continue Reading
HITRUST i1 Certification: The Gold Standard in Security For a world increasingly reliant on digital infrastructure, cybersecurity certification is no longer just a badge of honor; it's a cornerstone of trust. Dentistry.One nailed this down by bagging that coveted HITRUST i1 certification. When folks talk about securing data, HITRUST might as well be speaking gospel. We're...
Continue Reading
JiMMYBAR! Breaks New Ground in Supplements You ever notice how some companies just know how to shake things up? Take JiMMYBAR!, for instance. The moment I read they’re making moves to get their Creatine + Protein bars into Target stores nationwide, starting October 4, I thought, “That’s one way to drag creatine out from the dusty tub and onto the shelves of...
Continue Reading
A Missed Opportunity for Community Banks It's a classic tale: community banks sleepwalking while big players snatch up low-hanging fruit right in their own backyards. According to the latest report by Cornerstone Advisors, commissioned by Teslar Software, these banks are essentially leaving $106 billion on the table when it comes to consumer lending. That's not just chump...
Continue Reading
The Urgency of Liver Cancer Awareness Death doesn’t wait, does it? When liver cancer is the villain in question, every moment becomes precious because this beast doesn’t roar until it’s too late. Here we are in 2026, staring at nearly 31,000 annual deaths in the U.S. alone. But hope flickers with a new congressional resolution aiming to slap a bright spotlight on...
Continue Reading
Bringing Capital and Content Under One Roof There's something in the air as Itibari-Waynne & Partners (IWP) team up with the VYRE Network to crank out a fresh slate of content for VYRE Business News Global (VBNGtv). This partnership ain't just another splash in the buzzy world of digital media; it's like merging Wall Street with Hollywood. IWP, prepping to go full...
Continue Reading
Peering Into CNG's Latest Innovation Charter Next Generation (CNG) just threw down a hefty gauntlet with its launch of next-gen machine-direction-oriented polyethylene (MDO-PE) solutions. They're pushing the envelope on what recycle-ready packaging can do, folks. Let's not mince words—other players in the field better have their game faces on. This ain't just another...
Continue Reading
Top 5 Most Recently Viewed Articles
NewtekOne, Inc. Announces Quarterly Dividend Declaration NewtekOne, Inc. (NASDAQ: NEWT) has recently made an exciting announcement for its shareholders. The Board of Directors has declared a quarterly cash dividend amounting to $0.19 per share, which is a testament to the company's ongoing commitment to enhancing shareholder value. As the company gears up for this...
Continue Reading
Unveiling the Top Appreciating Wines of 2024 In a year that saw many challenges for the alcohol industry, high-end wines have emerged as a bright spot, showcasing resilience and appreciation. The Wine Market Journal, known as a premier resource for rare wine valuation, has released its definitive list of the top appreciating wines for the future. Insights from the Wine...
Continue Reading
Grainger Announces Quarterly Dividend for Shareholders W.W. Grainger, Inc. (NYSE: GWW) has declared a quarterly cash dividend of $2.26 per share. This announcement showcases the company’s unwavering commitment to providing consistent returns to its shareholders. The board of directors has approved this dividend, which signals the company's solid operational fundamentals...
Continue Reading
Seres Therapeutics Moves Forward with SER-155 Development The recent engagement between Seres Therapeutics, Inc. and the U.S. Food and Drug Administration (FDA) marks a significant milestone in the clinical development of SER-155, an innovative live biotherapeutic aimed at improving patient outcomes undergoing allogeneic hematopoietic stem cell transplant (allo-HSCT). The...
Continue Reading
Understanding the Real Estate Landscape for 2025 The real estate market is gearing up for a challenging 2025, marked by political instability and rising insurance costs. Recent insights from industry experts have outlined the top challenges anticipated in the upcoming year, reflecting a combination of geopolitical tensions and ongoing economic shifts. The Impact of...
Continue Reading